Morgan Stanley Sees Unusually High Options Volume (MS)

Marco Green
July 28, 2017

The fund owned 25,414 shares of the financial services provider's stock after buying an additional 5,250 shares during the period.

Several other large investors have also recently modified their holdings of the company. Park National Corp OH now owns 6,557 shares of the financial services provider's stock valued at $281,000 after buying an additional 65 shares during the last quarter. Lee Danner & Bass Inc. raised its position in Morgan Stanley by 0.3% in the first quarter. LGT Capital Partners LTD. now owns 292,900 shares of the financial services provider's stock valued at $12,548,000 after buying an additional 43,480 shares during the last quarter. BKD Wealth Advisors LLC increased its stake in shares of Morgan Stanley by 24.9% in the second quarter. FTB Advisors Inc. now owns 2,605 shares of the financial services provider's stock valued at $112,000 after buying an additional 196 shares during the last quarter. Finally, Adirondack Trust Co. raised its position in Morgan Stanley by 2.5% in the first quarter. The firm owned 81,187 shares of the financial services provider's stock after buying an additional 79,957 shares during the period. Hedge funds and other institutional investors own 85.28% of the company's stock.

Morgan Stanley (MLPY) shares have been sparking interest of late as the volume moving average (VMA) has climbed steadily over the past seven bars. In terms of Moving Averages, the 50-day is 593.40, the 200-day is at 594.83, and the 7-day is 614.10. The stock has a market cap of $86.65 billion, a P/E ratio of 13.49 and a beta of 1.63. The company rocked its 52-Week High of $48.04 and touched its 52-Week Low of $27.79.

Morgan Stanley (MS.N) aims to raise $500 million from clients for a new fund that will invest in niche assets that may hard to liquidate quickly and are too complicated for most private equity or hedge funds, according to a document seen by Reuters. Investors bought 19,289 put options on the company. The stock of Morgan Stanley (NYSE:MS) has "Outperform" rating given on Wednesday, October 7 by RBC Capital Markets. Morgan Stanley had a ROE of 9.86% and a net profit margin of 16.77%.

17 number of analysts have estimated the sales of the company for the quarter, analysts estimated mean sale target of 9256.41 million while high and low sale targets are estimated at 9723 million and 8799 million respectively. During the same quarter in the prior year, the firm earned $0.75 earnings per share. Morgan Stanley's revenue was up 6.7% on a year-over-year basis. Morgan Stanley (MS-E)'s Williams Percent Range or 14 day Williams %R now sits at -25.00.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Monday, July 31st will be issued a dividend of $0.25 per share. This is a non-inferiority study conducted to compare second-line treatment of the protease inhibitor-sparing regimen of dolutegravir and 2 nucleoside reverse transcriptase inhibitors (NRTIs), with a current WHO-recommended regimen of lopinavir/ritonavir and 2 NRTIs in HIV-1-infected adults. Investment Centers of America Inc.'s holdings in Morgan Stanley were worth $362,000 at the end of the most recent quarter. Morgan Stanley's yield ratio (DPR) is 22.92%.

Morgan Stanley announced that its board has initiated a share buyback plan on Wednesday, June 28th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 6.1% of its shares through open market purchases.

ILLEGAL ACTIVITY WARNING: "New England Research & Management Inc. Has $3.62 Million Position in Morgan Stanley (NYSE:MS)" was reported by Stock Observer and is owned by of Stock Observer. If you are accessing this story on another domain, it was stolen and reposted in violation of U.S. and worldwide trademark & copyright laws.

A number of analysts have recently weighed in on the company. Zacks Investment Research lowered Morgan Stanley from a "hold" rating to a "sell" rating in a research note on Tuesday, July 11th. Macquarie reissued an "outperform" rating and issued a $52.00 target price (up previously from $51.00) on shares of Morgan Stanley in a research note on Saturday, July 22nd. J P Morgan Chase & Co restated a "buy" rating and issued a $53.00 price target on shares of Morgan Stanley in a report on Monday, June 26th. Bank of America Corporation upped their price objective on Morgan Stanley from $50.00 to $51.00 and gave the stock a "buy" rating in a research report on Thursday, July 20th. S&P Research downgraded it to "Buy" rating and $38 target in Tuesday, October 20 report. Also, Chairman James P. Gorman sold 212,365 shares of the company's stock in a transaction dated Wednesday, May 10th. The stock was sold at an average price of $42.93, for a total value of $9,116,829.45. Following the transaction, the chairman now directly owns 1,389,378 shares of the company's stock, valued at approximately $59,645,997.54.

In other Morgan Stanley news, CFO Jonathan Pruzan unloaded 25,767 stocks of Morgan Stanley shares in a trade that took place on Thurs, Jul 20th. A reading under 30 may indicate that the stock is oversold, and possibly undervalued.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER